Consolidated Statements of Stockholders' Equity (Deficit) - USD ($) $ in Thousands	Total	Common Stock	Additional Pain In Capital	Accumulated Deficit	Accumulated Other Comprehensive Income (Loss)
Balance at Dec. 31, 2023	$ 170,175	$ 4	$ 550,943	$ (380,772)
Balance, shares at Dec. 31, 2023		43,270,386
Issuance of common stock upon exercise of stock options	189		189
Issuance of common stock upon exercise of stock options, shares		88,283
Issuance of common stock upon vesting of restricted stock, shares		148,980
Shares withheld for taxes	(141)		(141)
Shares withheld for taxes, shares		(67,813)
Issuance of common stock pursuant to at-the-market offering, net of issuance costs of $0.6 million, Amount	19,266	$ 1	19,265
Issuance of common stock pursuant to at-the-market offering, net of issuance costs of $0.6 million, Share		6,350,000
Issuance of common stock and pre-funded warrants pursuant to underwritten public offering, net of issuance costs of $6.3 million, Amount	91,652	$ 3	91,649
Issuance of common stock and pre-funded warrants pursuant to underwritten public offering, net of issuance costs of $6.3 million, Share		32,379,667
Stock-based compensation expense	5,679		5,679
Net Income (Loss)	(28,016)			(28,016)
Balance at Mar. 31, 2024	258,804	$ 8	667,584	(408,788)
Balance, shares at Mar. 31, 2024		82,169,503
Balance at Dec. 31, 2024	$ 186,609	$ 8	684,479	(497,894)	$ 16
Balance, shares at Dec. 31, 2024		82,569,168
Issuance of common stock upon exercise of stock options, shares	0
Issuance of common stock upon vesting of restricted stock, shares		256,913
Shares withheld for taxes	$ (104)		(104)
Shares withheld for taxes, shares		(116,456)
Other comprehensive income	(25)				(25)
Stock-based compensation expense	3,180		3,180
Net Income (Loss)	(28,214)			(28,214)
Balance at Mar. 31, 2025	$ 161,446	$ 8	$ 687,555	$ (526,108)	$ (9)
Balance, shares at Mar. 31, 2025		82,709,625